3.Remark on the mortality hemorrhagic fever in Viet Nam, year 2002
Journal of Practical Medicine 2003;442(2):89-91
42 cases of death due to hemorrhagic fever in the year 2002 showed that: they were mainly (90.5%) in South provinces, mainly at the age under 15 (90.5%). The most died within 48 hours after the admission into hospital (73.8%), 26.2% after 3nd day and 92.2% within 5-6 days after the recovery. 85.7% of deaths were at commune level and provincial level. Hemorrhagic common symptoms were usually: blood vomitting (47.6%), hemorrhagic points (42.9%), nasal hemorrhagic 47.6%, gengive hemorrhage 16.7% and erythema (11.9%)
Hemorrhagic Fevers, Viral
;
Mortality
;
Death
4.Research progress on the role of monocytes in viral hemorrhagic fevers.
Hongyan SHI ; Kang TANG ; Xuyang ZHENG ; Ying ZHANG
Chinese Journal of Cellular and Molecular Immunology 2023;39(8):748-752
Monocytes are important target cells of various hemorrhagic fever viruses. In viral hemorrhagic fevers (VHFs), monocytes can be infected by viruses and produce different kinds of cytokines, which contribute to the antiviral immune response and participation in the immunopathogenesis of VHFs. During the pathogenesis of various VHFs (early stage), monocytes change in cell counting, subpopulation distribution and expression of surface molecules with an activated phenotype. Several hemorrhagic fever viruses can infect monocytes and induce immune response, which may play an important role in immunopathological injury. Monocytes and the cytokines they produce may interact with platelets and vascular endothelial cells, contributing to disease progression.
Humans
;
Monocytes
;
Endothelial Cells
;
Hemorrhagic Fevers, Viral/pathology*
;
Immunity
;
Cytokines
5.Serum and Urinary Fibrin/Fibrinogen Degradation Products in Patients with Korean Hemorrhagic Fever; With Particular Reference to Disseminated Intravascular Coagulation and Acute Renal Failure.
Byung Ro KIM ; Sang Ho CHO ; In Joon CHOI ; Dong Sik KIM
Yonsei Medical Journal 1974;15(2):103-114
Korean hemorrhagic fever is a disease with an acute onset of severe hemorrhagic tendency and acute renal failure. Acute renal failure may be produced by inducing intravascular coagulation in experimental animals, and also, coagulation mechanisms may play a pathogenetic role in certain human renal diseases. One of the clinical consequences of DIC is serious ischemic tissue damage due to capillary flow blocking by fibrin deposits. The kidney is particularly vulnerable to ischemic effects. For the detection of intravascular coagulation, FDP assay is known as a more sensitive and reliable test than are other coagulation studies. Therefore, from September, 1973 to January, l974, the serum and the urine of the selected patients with Korean hemorrhagic fever who had a typical clinical course were subjected to study. The alterations of the serum and urinary FDP concentrations, and the other hematologic, blood chemistry, and urinary examinations were studied in a total of 177 examples of each febrile, hypotensive, oliguric, diuretic, and convalescent phase. Both the serum and urinary FDP concentrations were significantly higher than normal. This data indicates that DIC is detected in Korean hemorrhagic fever, where it may play a major pathogenetic role. And the urinary FDP concentration more closely reflects the severity of renal lesions in this disease than does the serum FDP concentration and the blood urea nitrogen level. It can be assumed that the concentration of urinary FDP can be used as a therapeutic criteria, and is correlated to the intensity and the prognosis of the disease. Also the possibility of improvement following anticoagulant treatment may be proposed. It appears that acute renal failure in this disease has a close relationship to DIC. In its pathogenesis it can be assumed that disruption of the renal cortical perfusion plays a major role in this Korean hemorrhagic fever.
Blood Urea Nitrogen
;
Disseminated Intravascular Coagulation/etiology*
;
Disseminated Intravascular Coagulation/metabolism
;
Female
;
Fibrin Fibrinogen Degradation Products/metabolism*
;
Hemorrhagic Fevers, Viral/blood*
;
Hemorrhagic Fevers, Viral/urine
;
Human
;
Kidney Failure, Acute/etiology*
;
Korea
;
Male
6.Cutaneous Manifestations of Potential Chemical, Biological, and Radiological Agents and Their Clinical Management.
Jun Young LEE ; Byung Sub KIM ; Young Min PARK
Korean Journal of Dermatology 2016;54(9):683-692
The level of terrorist threats using chemical, biological, and radiological agents has been continuously increasing, and it is an undeniable truth that these agents are actually in use today. The fact that most chemical, biological, and radiological agents cause skin-related symptoms, and that the skin symptoms are observed at a relatively early stage of the condition, leads to the conclusion that dermatologists could be the first point of contact for potential victims of these agents. It is highly important that first responders are able to recognize symptoms caused by these agents early and react quickly. Therefore, dermatologists do have a responsibility to take on a role in dealing with chemical, biological, and radiological attacks, and pre-equip themselves with professional knowledge in this field. Among the various types of chemical agents, typical examples of agents causing skin-related symptoms are blistering agents, which lead to bullae and necrosis on the skin. Biological agents are classified from Category A to C according to their respective risk factors. The most dangerous Category A agents include anthrax, smallpox, plague, tularemia, and viral hemorrhagic fever, all of which are known to show characteristic skin-related symptoms. Upon exposure to a certain level of radiation, radiological agents can also lead to erythema on the skin. In this article, we will discuss various characteristics and up-to-date treatment methods of potential chemical, biological, and radiological agents to help dermatologists advance their knowledge in this field.
Anthrax
;
Biological Factors
;
Blister
;
Erythema
;
Hemorrhagic Fevers, Viral
;
Necrosis
;
Plague
;
Risk Factors
;
Skin
;
Smallpox
;
Terrorism
;
Tularemia
;
Weapons
7.Cutaneous Manifestations of Potential Chemical, Biological, and Radiological Agents and Their Clinical Management.
Jun Young LEE ; Byung Sub KIM ; Young Min PARK
Korean Journal of Dermatology 2016;54(9):683-692
The level of terrorist threats using chemical, biological, and radiological agents has been continuously increasing, and it is an undeniable truth that these agents are actually in use today. The fact that most chemical, biological, and radiological agents cause skin-related symptoms, and that the skin symptoms are observed at a relatively early stage of the condition, leads to the conclusion that dermatologists could be the first point of contact for potential victims of these agents. It is highly important that first responders are able to recognize symptoms caused by these agents early and react quickly. Therefore, dermatologists do have a responsibility to take on a role in dealing with chemical, biological, and radiological attacks, and pre-equip themselves with professional knowledge in this field. Among the various types of chemical agents, typical examples of agents causing skin-related symptoms are blistering agents, which lead to bullae and necrosis on the skin. Biological agents are classified from Category A to C according to their respective risk factors. The most dangerous Category A agents include anthrax, smallpox, plague, tularemia, and viral hemorrhagic fever, all of which are known to show characteristic skin-related symptoms. Upon exposure to a certain level of radiation, radiological agents can also lead to erythema on the skin. In this article, we will discuss various characteristics and up-to-date treatment methods of potential chemical, biological, and radiological agents to help dermatologists advance their knowledge in this field.
Anthrax
;
Biological Factors
;
Blister
;
Erythema
;
Hemorrhagic Fevers, Viral
;
Necrosis
;
Plague
;
Risk Factors
;
Skin
;
Smallpox
;
Terrorism
;
Tularemia
;
Weapons
8.Laboratory diagnosis of viral hemorrhagic fevers.
Chinese Journal of Virology 2013;29(3):349-356
Viral hemorrhagic fevers (VHFs) refer to a group of acute infections with high case fatality rates that are caused by four distinct families of RNA viruses belonging to the families Bunyaviridae, Flaviviridae, Filoviridae and Arenaviridae, the main clinical symptoms of these diseases are accompanied by fever and bleeding. For the reason that these infections have similar primary clinical symptoms, it is difficult to diagnose and distinguish them; rapid and reliable laboratory diagnostic tests are required in suspected cases for epidemiological investigation and controlling the spread of VHFs. This review addresses the laboratory diagnostics of VHFs, covering etiological classification and different diagnostic techniques, such as virus isolation, nucleic acid detection, as well as antigen and antibody assays. Prospects for novel diagnostic tools are also discussed.
Clinical Laboratory Techniques
;
methods
;
Hemorrhagic Fevers, Viral
;
diagnosis
;
immunology
;
virology
;
Humans
;
RNA Viruses
;
genetics
;
immunology
;
isolation & purification
9.Meningitis following vaccination with yellow-fever vaccine.
Seong Yeol RYU ; Young Ran JU ; Young Eui JEONG ; Myung Guk HAN ; Nam Hi RYOO
Korean Journal of Medicine 2009;76(Suppl 1):S204-S207
Yellow fever is the original viral hemorrhagic fever (VHF), a pansystemic viral sepsis with viremia, fever, prostration, hepatic, renal, and myocardial injury, hemorrhage, shock, and high lethality. Yellow fever was one of the most feared lethal diseases before the development of an effective vaccine. Yellow fever (YF) can be prevented by an attenuated vaccine. The yellow-fever 17D vaccine developed in the 1930s has been regarded as one of the most successful live attenuated vaccines, with few side effects or adverse events. The adverse effects associated with yellow-fever vaccine are generally mild and include headache, myalgia, and low-grade fever. Recently, however, some cases of severe neurologic disease and multi-organ system disease have been described in individuals who received yellow-fever vaccine. We report the case of a 39-year-old female with meningitis following vaccination with 17D yellow-fever vaccine.
Adult
;
Female
;
Fever
;
Headache
;
Hemorrhage
;
Hemorrhagic Fevers, Viral
;
Humans
;
Meningitis
;
Sepsis
;
Shock
;
Vaccination
;
Vaccines, Attenuated
;
Viremia
;
Yellow Fever
10.Epidemiological study on data involving 61 hospitalized cases with Huaiyangshan hemorrhagic fever in Wuhan.
Bin YU ; Wen-yong WANG ; Jun-hua TIAN ; De-yuang KONG ; Yong-xia QUAN ; Yong-an DAI ; Qi-fa WANG ; Tong-yong LIU ; Quan HU ; Yong-wen HE
Chinese Journal of Epidemiology 2012;33(1):124-125
Adult
;
Aged
;
Aged, 80 and over
;
China
;
epidemiology
;
Female
;
Hemorrhagic Fevers, Viral
;
epidemiology
;
Hospitalization
;
Humans
;
Male
;
Middle Aged